Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.

Blood
S D RowleyF R Appelbaum

Abstract

The experiences of 69 (38 marrow and 31 peripheral blood stem cell [PBSC]) donors participating in a randomized trial comparing allogeneic bone marrow with PBSC transplantation were studied. Marrow was collected by means of standard harvest techniques and general or regional anesthesia. PBSC donors were treated with 5 to 7 days of filgrastim at a dose of 16 microg/kg/d and underwent 1 to 3 days of apheresis to obtain 5 x 10(6) CD34(+) cells per kilogram recipient weight. Donors completed questionnaires describing their health experiences before, during, and then weekly after donation until return to baseline status. Both marrow and PBSC donors reported minimal fluctuation in symptoms measuring emotional status. In contrast, both groups of donors reported deterioration in physical status starting with administration of filgrastim (PBSC donors) or after the marrow collection procedure. The symptom burden reported was similar, with pain a prominent symptom for both groups. Equivalent mean levels of maximal pain, average pain, and pain duration through the day were reported, although toxicity peaks occurred at different time points during the harvest procedures. All PBSC donors but only 79% of marrow donors reported good physical s...Continue Reading

References

May 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M BrandweinA Keating
Jun 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BeyerW Stieger
Mar 1, 1997·Bone Marrow Transplantation·D PrzepiorkaM Körbling
May 1, 1997·British Journal of Haematology·P AnderliniM Körbling

❮ Previous
Next ❯

Citations

Oct 28, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Gary Donaldson
Jan 22, 2004·Archives of Medical Research·Sally Arai, Hans-G Klingemann
Sep 25, 2002·Critical Reviews in Oncology/hematology·Louis M PelusAndrew G King
Jul 18, 2002·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Masaharu KasaiAkio Kawamura
Jul 16, 2008·Bone Marrow Transplantation·H LannertA D Ho
Nov 27, 2007·Bone Marrow Transplantation·J D Fish, S A Grupp
Apr 12, 2005·Bone Marrow Transplantation·T ParkkaliT Ruutu
Mar 21, 2007·Bone Marrow Transplantation·A F CashenS M Devine
Mar 27, 2012·Expert Opinion on Biological Therapy·Massimo MartinoFortunato Morabito
Oct 15, 2011·Blood Reviews·Karin AmreinCamilla Drexler
Aug 10, 2010·Transplantation Proceedings·A Bosi, B Bartolozzi
Aug 18, 2009·British Journal of Haematology·Derwood PamphilonSimon Stanworth
May 18, 2004·Vox Sanguinis·J SchanzJ Riggert
May 31, 2007·Psycho-oncology·Lori S WienerTerry Fry
Nov 16, 2004·Anesthesiology Clinics of North America·Marie Csete
Jan 27, 2016·Journal of Adolescent and Young Adult Oncology·Meaghann S WeaverBrandon Triplett
Mar 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Linda J BurnsUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Nov 5, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Galen E SwitzerJohn R Wingard
Apr 2, 2002·Best Practice & Research. Clinical Haematology·N H Russell, J L Byrne
Mar 21, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Yukiko KomenoUNKNOWN Japan Hematology and Oncology Clinical Study Group
Oct 23, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Willis H NavarroMichael Pulsipher
May 19, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christopher BredesonJeff Lipton
Feb 1, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Vivian G OehlerWilliam Bensinger
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven M DevineJohn F DiPersio
Oct 17, 2003·Bone Marrow Transplantation·G FavreUNKNOWN European Group for Blood and Marrow Transplantation (EBMT)
Nov 25, 2003·Hematology·Michele H Cottler-FoxSteven Devine
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Samreen SiddiqSimon Stanworth
Jul 7, 2017·Stem Cells International·Irene RiezzoEmanuela Turillazzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.